This paper discusses how stem cell-based therapies are moving toward clinical practice for the treatment of brain injuries in newborns, such as hypoxic-ischemic encephalopathy. These injuries can have lifelong consequences if not addressed early.

The authors review the science, safety, and early clinical experience, offering a hopeful look at how regenerative medicine may help the most vulnerable patients.

This is a research reference from our clinical library. Approved by the Chambers Clinic Team — last reviewed May 28, 2026.